Global IRT Leadership Cenduit is a leading IRT systems specialist with rapid study startup software, RTSM, and clinical supply management capabilities. Its global expert network and extensive trial footprint enable multinational studies with fast initialization and consistent supply planning, creating opportunities to cross-sell end-to-end IRT, integration, and forecasting services to large sponsors and CROs.

End-to-End Bundle Potential Given Cenduit's integrated offerings across patient randomization, RTSM, integration, patient engagement and materials forecasting, there is a strong case for selling bundled solutions that reduce vendor management complexity and shorten study timelines for sponsors and CROs.

Global Footprint Advantage Their global reach across regions and experience with trials in numerous countries and sites provides credibility for multinational programs and consistent regulatory and process standards, appealing to sponsors running global trials.

Enterprise Partnership Strength A history as a joint venture involving Quintiles (IQVIA) and Thermo Fisher Scientific signals deep pharma and CRO relationships and capacity for enterprise-scale deals, co-development, and long-term partnerships in IRT and related data workflows.

Growth Credibility Boost Recognitions and leadership appointments in recent years underscore growth, stability and market credibility, supporting conversations around larger budgets, security, and expansion into key markets such as North America.